Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4188)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 15, 2023 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu X, Yang Y. Research progress on drug delivery systems for curcumin in the treatment of gastrointestinal tumors. World J Gastrointest Oncol 2023; 15(8): 1342-1348 [PMID: 37663948 DOI: 10.4251/wjgo.v15.i8.1342] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i8/1342.htm |
| Number | Citing Articles |
| 1 |
Mahdieh Teimouri, Masoud Homayouni Tabrizi, Ehsan Karimi. The selective proapoptotic impact of the myricetin-loaded alginate-cellulose hybrid nanocrystals (MAC-NCs) on the human AGS gastric cancer cells. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09864-0
|
| 2 |
Soheyla Karimi, Hassan Namazi. Doxorubicin-curcumin-co loaded layered double hydroxide coated with dialdehyde lactose/ZnO via Schiff-base bonding for simultaneous and targeted delivery of drugs to Hepatocellular carcinoma cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2025; 715: 136628 doi: 10.1016/j.colsurfa.2025.136628
|
| 3 |
Mahdi Shadnoush, Mehrnaz Momenan, Veronique Seidel, Sascha Tierling, Nayeralsadat Fatemi, Ehsan Nazemalhosseini-Mojarad, Mohammad Tayefeh Norooz, Makan Cheraghpour. A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer. Pharmacological Reports 2025; 77(1): 103 doi: 10.1007/s43440-024-00652-y
|